AIDS and HIV Research
Acquired Immune Deficiency Syndrome (AIDS) is a disease characterized by a progressive loss of immune system function, manifested by numerous opportunistic infections, including tumors. Untreated, it is universally fatal, but recent advances in treatment have made the disease much more manageable and many patients can lead relatively normal lives. Human immunodeficiency virus (HIV) is the virus that causes AIDS. HIV is a retrovirus that infects immune cells and some neurons. There is no cure for AIDS and there is no drug that can eliminate HIV from the body. There are many anti-retroviral drugs however that can reduce HIV plasma levels to very low levels and restore immune system function.
AIDS is the most severe manifestiation of HIV infection. AIDS occurs due to the progressive destruction of CD4+ T cells. AIDS is defined as the presence of a cluster of symptoms outlined below and often when CD4+ T cells drop to fewer than 200 per microliter of blood.
Other opportunistic infections that are common in patients with AIDS include infection with Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV) and human papillomavirus (HPV). EBV and KSHV are common causes of high-grade lymphomas in AIDS patients. Cervical cancer in HIV-infected women is also common. Other more mild infections include mycobacterium avium-intracellulare and cytomegalovirus (CMV). Penicillosis has become a common infection in HIV-positive patients in southeast Asia.
HAART has resulted in a dramatic decrease in HIV-related mortality (and morbidity). HAART seems to increase survival time by at least 4 years and some studies suggest as much as 12 years. Without HAART, the progression of HIV to AIDS occurs in about 10 years. Many HIV-positive patients develop a drug-resistant strain of HIV. Side effects can include diarrhea, insulin resistance, cholesterol disorders and lipodystrophy.




